BIO CHART, page-32

After spending its initial year in a market unsupportive of growth stocks, in early 2023 BIO’s share price commenced a period of rapid growth reflecting the dynamic approach adopted by management to product development and market expansion.

A simple share price chart plotted on a log scale shows BIO to have established a trend channel that corresponds to an annualised growth rate of +470% p.a. With price in the lower half of the channel, both MACD and Stochastic RSI metrics indicate BIO currently to be oversold on a daily basis.



This observed high level of price growth aligns with that achieved for revenue over the same period, and the associated rate of growth in future earnings that can be projected at the margin.

Business expansion recently articulated by management for the next three years, if achieved, should see continuation of growth of this order, at least in the near term.

All IMO
T7